Day: June 3, 2022

Rescheduled to June 16, 2022, at 1:00pm Eastern Time Menlo Park, CA, June 03, 2022 (GLOBE NEWSWIRE) —  Summit Therapeutics Inc. (NASDAQ: SMMT) invites our shareholders and other interested parties to attend our Company’s Annual Shareholders’ Meeting, which will now be held virtually on Thursday, June 16, 2022, at 1:00 pm Eastern Time, one day later than previously planned. We are providing notice of the change in advance to allow for accommodation for attendance. We look forward to your attendance at this meeting. As a reminder, in order to vote and/or submit questions during our Annual Shareholders’ Meeting, attendees must log into the virtual meeting with their unique control number provided with their 2022 Summit Therapeutics proxy statement and annual meeting information. This information was provided to shareholders as of...

BOSTON, June 03, 2022 (GLOBE NEWSWIRE) — DraftKings Inc. (Nasdaq: DKNG) (“DraftKings” or the “Company”) today announced that Jason Robins, the Company’s co-founder, Chief Executive Officer and Chairman of the Board, will participate in the following event:The Goldman Sachs Travel and Leisure Conference on June 6, 2022. The fireside chat is scheduled for 10:40AM ET.Registration and the live video and audio portions of the Goldman Sachs Travel and Leisure Conference can be accessed at the conference website or at DraftKings’ Investor Relations website. About DraftKings DraftKings Inc. is a digital sports entertainment and gaming company created to fuel the competitive spirit of sports fans with products that range across daily fantasy, regulated gaming and digital media. Headquartered in Boston, and launched in 2012 by Jason...

MIAMI, June 03, 2022 (GLOBE NEWSWIRE) — Watsco, Inc. (NYSE: WSO) announced today that Barry Logan, Executive Vice President, is scheduled to present at the William Blair 42nd Annual Growth Stock Conference being held at the Loews Chicago Hotel on Thursday, June 9, 2022 at 8:00 a.m. (CDT). Internet users can listen to a live webcast of the presentation at the Investor Relations section of Watsco’s website at http://www.watsco.com. About Watsco, Inc. Watsco is the largest distribution network for heating, air conditioning and refrigeration (HVAC/R) products with locations in the United States, Canada, Mexico and Puerto Rico, and on an export basis to Latin America and the Caribbean. Watsco estimates that over 350,000 contractors and technicians visit or call one of its 671 locations each year to get information, obtain technical...

MIAMI, June 03, 2022 (GLOBE NEWSWIRE) — Watsco, Inc. (NYSE: WSO) announced today that Barry Logan, Executive Vice President, is scheduled to present at Baird’s Global Consumer, Technology & Services Conference being held at the InterContinental New York Barclay hotel on Tuesday, June 7, 2022 at 11:25 a.m. (EDT). Internet users can listen to a live webcast of the presentation at the Investor Relations section of Watsco’s website at http://www.watsco.com. About Watsco, Inc. Watsco is the largest distribution network for heating, air conditioning and refrigeration (HVAC/R) products with locations in the United States, Canada, Mexico and Puerto Rico, and on an export basis to Latin America and the Caribbean. Watsco estimates that over 350,000 contractors and technicians visit or call one of its 671 locations each year to get information,...

WALTHAM, Mass., June 03, 2022 (GLOBE NEWSWIRE) — Dyne Therapeutics, Inc. (Nasdaq: DYN), a muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases, today announced that management is scheduled to participate in a fireside chat at the Jefferies Global Healthcare Conference being held in New York, NY on Thursday, June 9, 2022 at 3:00 p.m. ET. A live webcast will be available in the Investors & Media section of Dyne’s website at https://investors.dyne-tx.com/news-and-events/events-and-presentations and a replay will be accessible for 90 days following the presentation. About Dyne Therapeutics Dyne Therapeutics is building a leading muscle disease company dedicated to advancing innovative life-transforming therapeutics for people living with genetically...

GAITHERSBURG, Md., June 03, 2022 (GLOBE NEWSWIRE) — Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that members of the Company’s management team will participate at the following investor conferences in June 2022:Jefferies 2022 Global Healthcare Conference in New York, NYFriday, June 10, 2022Fireside chat at 10:00 am Eastern TimeJMP Securities Life Sciences Conference in New York, NYThursday, June 16, 2022Fireside chat at 9:00 am Eastern TimeThe sessions will be webcast and can be accessed by visiting the Events section of the Altimmune website. About AltimmuneAltimmune is a clinical-stage biopharmaceutical company focused on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. The company’s lead product candidate, pemvidutide (ALT-801),...

Initiating a 1,000-Metre Follow-Up Drilling and Geophysical Survey program on its Highly Prospective Moribala PermitFigure 1 Planned RC drill hole locations on high-priority target zones at MoribalaNot for distribution to United States newswire services or for dissemination in the United States TORONTO, June 03, 2022 (GLOBE NEWSWIRE) — Compass Gold Corporation (TSX-V: CVB) (“Compass” or the “Company”) announced today that it has issued, on a non-brokered private placement basis, a total of 7,298,668 units of the Company (“Units“), at a price of $0.15 per Unit, for aggregate gross proceeds of approximately $1.1 million pursuant to the closing of its previously announced private placement (the “Offering”) (see Compass news release dated April 21, 2022). Larry Phillips, Compass Gold’s...